John Hilton

8.1k total citations
162 papers, 2.6k citations indexed

About

John Hilton is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, John Hilton has authored 162 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 102 papers in Oncology, 55 papers in Pulmonary and Respiratory Medicine and 43 papers in Cancer Research. Recurrent topics in John Hilton's work include Advanced Breast Cancer Therapies (28 papers), Breast Cancer Treatment Studies (28 papers) and Cancer Treatment and Pharmacology (25 papers). John Hilton is often cited by papers focused on Advanced Breast Cancer Therapies (28 papers), Breast Cancer Treatment Studies (28 papers) and Cancer Treatment and Pharmacology (25 papers). John Hilton collaborates with scholars based in Canada, United States and United Kingdom. John Hilton's co-authors include Bart Barlogie, S Jagannath, Guido Tricot, Nikhil C. Munshi, DH Vesole, Mark Clemons, Brian Hutton, Sasha Mazzarello, Lisa Vandermeer and R. F. Rosenberger and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

John Hilton

154 papers receiving 2.6k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
John Hilton 1.2k 828 616 421 364 162 2.6k
Gregory D. Ayers 792 0.6× 961 1.2× 317 0.5× 227 0.5× 401 1.1× 55 2.7k
Sun‐Young Kong 1.3k 1.1× 1.4k 1.7× 498 0.8× 425 1.0× 683 1.9× 204 3.7k
Urban Emmenegger 1.5k 1.3× 1.3k 1.6× 923 1.5× 359 0.9× 930 2.6× 150 3.4k
Giannis Mountzios 1.6k 1.3× 1.0k 1.2× 971 1.6× 160 0.4× 507 1.4× 124 3.2k
Marco Danova 1.6k 1.3× 1.1k 1.4× 576 0.9× 553 1.3× 634 1.7× 226 3.5k
Catherine Wheeler 1.7k 1.4× 1.1k 1.4× 520 0.8× 1.1k 2.6× 473 1.3× 73 3.6k
Christoph Mundhenke 906 0.7× 703 0.8× 403 0.7× 124 0.3× 399 1.1× 106 2.3k
Jeri Kim 1.2k 1.0× 1.3k 1.5× 1.5k 2.4× 251 0.6× 581 1.6× 101 3.3k
Samuel A. Jacobs 1.4k 1.1× 620 0.7× 450 0.7× 279 0.7× 329 0.9× 143 2.9k
Ramzi Dagher 848 0.7× 982 1.2× 656 1.1× 449 1.1× 261 0.7× 39 2.6k

Countries citing papers authored by John Hilton

Since Specialization
Citations

This map shows the geographic impact of John Hilton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Hilton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Hilton more than expected).

Fields of papers citing papers by John Hilton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Hilton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Hilton. The network helps show where John Hilton may publish in the future.

Co-authorship network of co-authors of John Hilton

This figure shows the co-authorship network connecting the top 25 collaborators of John Hilton. A scholar is included among the top collaborators of John Hilton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Hilton. John Hilton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Carneiro, Benedito A., Olumide B. Gbolahan, Albiruni R. Abdul Razak, et al.. (2025). First-in-Human Study to Evaluate the Safety and Efficacy of Anti-GDF15 Antibody AZD8853 in Patients with Advanced/Metastatic Solid Tumors. Cancer Research Communications. 5(6). 896–905. 1 indexed citations
2.
3.
4.
McGee, Sharon F., Mark Clemons, Gregory R. Pond, et al.. (2024). A Randomized Trial Comparing Concurrent versus Sequential Radiation and Endocrine Therapy in Early-Stage, Hormone-Responsive Breast Cancer. Current Oncology. 31(8). 4531–4545. 2 indexed citations
5.
Michel, Loren S., Antonio Jimeno, Ammar Sukari, et al.. (2024). Sacituzumab Govitecan in Patients with Relapsed/Refractory Advanced Head and Neck Squamous Cell Carcinoma: Results from the Phase II TROPiCS-03 Basket Study. Clinical Cancer Research. 31(5). 832–838. 9 indexed citations
6.
Gelmon, Karen A., Jean-François Boileau, Christine Brezden‐Masley, et al.. (2024). Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with HER2+ Breast Cancer in Both the Early and Metastatic Setting. Current Oncology. 31(11). 6536–6567. 1 indexed citations
7.
Hilton, John, Patrick A. Ott, Aaron R. Hansen, et al.. (2024). INDUCE-2: A Phase I/II, open-label, two-part study of feladilimab in combination with tremelimumab in patients with advanced solid tumors. Cancer Immunology Immunotherapy. 73(3). 44–44. 10 indexed citations
8.
Cheng, Michael L., Jaclyn LoPiccolo, Mizuki Nishino, et al.. (2023). Exceptional Response to Bromodomain and Extraterminal Domain Inhibitor Therapy With BMS-986158 in BRD4-NUTM1 NUT Carcinoma Harboring a BRD4 Splice Site Mutation. JCO Precision Oncology. 7(7). e2200633–e2200633. 4 indexed citations
9.
Kendzerska, Tetyana, Brian J. Murray, Andrea S. Gershon, et al.. (2023). Polysomnographic Assessment of Sleep Disturbances in Cancer Development. CHEST Journal. 164(2). 517–530. 2 indexed citations
10.
11.
12.
Cescon, David W., John Hilton, Serafín Morales, et al.. (2023). A Phase I/II Study of GSK525762 Combined with Fulvestrant in Patients with Hormone Receptor–positive/HER2-negative Advanced or Metastatic Breast Cancer. Clinical Cancer Research. 30(2). 334–343. 10 indexed citations
13.
Hilton, John, et al.. (2023). Regularly scheduled physical examinations and the detection of breast cancer recurrences. The Breast. 69. 274–280. 10 indexed citations
14.
Kendzerska, Tetyana, Andrea S. Gershon, Marcus Povitz, et al.. (2021). Polysomnographic Markers of Obstructive Sleep Apnea Severity and Cancer-related Mortality: A Large Retrospective Multicenter Clinical Cohort Study. Annals of the American Thoracic Society. 19(5). 807–818. 10 indexed citations
15.
Dent, Susan, Dean Fergusson, Olexiy Aseyev, et al.. (2021). A Randomized Trial Comparing 3- versus 4-Monthly Cardiac Monitoring in Patients Receiving Trastuzumab-Based Chemotherapy for Early Breast Cancer. Current Oncology. 28(6). 5073–5083. 6 indexed citations
16.
17.
Dudani, Shaan, Sasha Mazzarello, John Hilton, et al.. (2016). Optimal Management of Leptomeningeal Carcinomatosis in Breast Cancer Patients—A Systematic Review. Clinical Breast Cancer. 16(6). 456–470. 22 indexed citations
18.
Fralick, Michael, et al.. (2012). Dual Blockade of HER2 — Twice as Good or Twice as Toxic?. Clinical Oncology. 24(9). 593–603. 3 indexed citations
19.
Hilton, John. (2004). Ayres, or Fa La's for Three Voyces (1627). 1 indexed citations
20.
Gutin, Philip H., et al.. (1977). DNA damage in the intracerebral rat gliosarcoma 9L treated with 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 37(10). 3761–5. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gregory D. Ayers Breakdown of academic impact, for papers by Sun‐Young Kong Breakdown of academic impact, for papers by Urban Emmenegger Breakdown of academic impact, for papers by Giannis Mountzios Breakdown of academic impact, for papers by Marco Danova Breakdown of academic impact, for papers by Catherine Wheeler Breakdown of academic impact, for papers by Christoph Mundhenke Breakdown of academic impact, for papers by Jeri Kim Breakdown of academic impact, for papers by Samuel A. Jacobs Breakdown of academic impact, for papers by Ramzi Dagher
Rankless by CCL
2026